Dynamics of serum antithyroglobulin antibodies in patients with differentiated thyroid cancer.

There was no impact of sTgAb on the initial clinical presentation and the response to therapy in low-risk patients treated with or without RA. sTgAb trend is more useful than an absolute value to predict a SIR.